[1]
Dr. Rohan et al. 2026. THE COMPREHENSIVE STUDY ON NOVEL ANGIOGENIC AND ANTI-ANGIOGENIC BIOMARKERS (E.G., SFLT-1/PLGF RATIOS) TO PREDICT AND MANAGE PRE-TERM PRE-ECLAMPSIA. Journal of Population Therapeutics and Clinical Pharmacology. 32, 11 (Sep. 2026), 2576–2585. DOI:https://doi.org/10.69980/es7wh926.